Annual EBITDA
-$20.99 M
-$5.41 M-34.74%
December 31, 2023
Summary
- As of February 26, 2025, CLPT annual EBITDA is -$20.99 million, with the most recent change of -$5.41 million (-34.74%) on December 31, 2023.
- During the last 3 years, CLPT annual EBITDA has fallen by -$16.20 million (-338.37%).
- CLPT annual EBITDA is now -632.37% below its all-time high of -$2.87 million, reached on December 31, 2012.
Performance
CLPT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$4.68 M
-$401.00 K-9.38%
September 30, 2024
Summary
- As of February 26, 2025, CLPT quarterly EBITDA is -$4.68 million, with the most recent change of -$401.00 thousand (-9.38%) on September 30, 2024.
- Over the past year, CLPT quarterly EBITDA has dropped by -$203.00 thousand (-4.54%).
- CLPT quarterly EBITDA is now -262.71% below its all-time high of $2.87 million, reached on March 31, 2014.
Performance
CLPT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$16.99 M
-$203.00 K-1.21%
September 30, 2024
Summary
- As of February 26, 2025, CLPT TTM EBITDA is -$16.99 million, with the most recent change of -$203.00 thousand (-1.21%) on September 30, 2024.
- Over the past year, CLPT TTM EBITDA has increased by +$4.05 million (+19.26%).
- CLPT TTM EBITDA is now -1055.29% below its all-time high of -$1.47 million, reached on June 30, 2011.
Performance
CLPT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CLPT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -34.7% | -4.5% | +19.3% |
| 3 y3 years | -338.4% | -31.4% | -69.7% |
| 5 y5 years | -313.7% | -451.2% | -292.1% |
CLPT EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -64.7% | at low | -29.0% | +31.1% | -33.3% | +19.3% |
| 5 y | 5-year | -384.3% | at low | -335.9% | +31.1% | -292.1% | +19.3% |
| alltime | all time | -632.4% | at low | -262.7% | +31.1% | -1055.3% | +19.3% |
ClearPoint Neuro EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$4.68 M(+9.4%) | -$16.99 M(+1.2%) |
| Jun 2024 | - | -$4.28 M(+13.8%) | -$16.79 M(-13.0%) |
| Mar 2024 | - | -$3.76 M(-12.3%) | -$19.30 M(-8.0%) |
| Dec 2023 | -$20.99 M(+34.7%) | -$4.28 M(-4.3%) | -$20.99 M(-0.3%) |
| Sep 2023 | - | -$4.47 M(-34.1%) | -$21.05 M(+4.2%) |
| Jun 2023 | - | -$6.79 M(+24.8%) | -$20.20 M(+16.2%) |
| Mar 2023 | - | -$5.44 M(+25.4%) | -$17.37 M(+11.5%) |
| Dec 2022 | -$15.58 M(+22.2%) | -$4.34 M(+19.7%) | -$15.58 M(+3.5%) |
| Sep 2022 | - | -$3.63 M(-8.7%) | -$15.04 M(+0.4%) |
| Jun 2022 | - | -$3.97 M(+8.9%) | -$14.98 M(+4.5%) |
| Mar 2022 | - | -$3.65 M(-4.2%) | -$14.33 M(+12.5%) |
| Dec 2021 | -$12.74 M(+166.2%) | -$3.81 M(+7.0%) | -$12.74 M(+27.3%) |
| Sep 2021 | - | -$3.56 M(+7.1%) | -$10.01 M(+30.7%) |
| Jun 2021 | - | -$3.32 M(+61.4%) | -$7.66 M(+34.0%) |
| Mar 2021 | - | -$2.06 M(+91.8%) | -$5.72 M(+19.4%) |
| Dec 2020 | -$4.79 M(+10.5%) | -$1.07 M(-10.9%) | -$4.79 M(-5.4%) |
| Sep 2020 | - | -$1.20 M(-12.8%) | -$5.06 M(+7.6%) |
| Jun 2020 | - | -$1.38 M(+22.2%) | -$4.71 M(+3.3%) |
| Mar 2020 | - | -$1.13 M(-16.2%) | -$4.56 M(+5.2%) |
| Dec 2019 | -$4.33 M(-14.6%) | -$1.35 M(+58.9%) | -$4.33 M(+10.1%) |
| Sep 2019 | - | -$848.50 K(-31.1%) | -$3.94 M(-7.2%) |
| Jun 2019 | - | -$1.23 M(+35.8%) | -$4.24 M(-8.1%) |
| Mar 2019 | - | -$906.30 K(-4.8%) | -$4.62 M(-9.0%) |
| Dec 2018 | -$5.07 M(-17.9%) | -$951.70 K(-17.6%) | -$5.07 M(-14.6%) |
| Sep 2018 | - | -$1.16 M(-28.0%) | -$5.94 M(-0.5%) |
| Jun 2018 | - | -$1.60 M(+17.8%) | -$5.98 M(-2.6%) |
| Mar 2018 | - | -$1.36 M(-25.3%) | -$6.13 M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | -$6.18 M(-10.0%) | -$1.82 M(+53.5%) | -$6.18 M(+6.7%) |
| Sep 2017 | - | -$1.19 M(-32.6%) | -$5.79 M(-16.0%) |
| Jun 2017 | - | -$1.76 M(+25.3%) | -$6.89 M(+4.2%) |
| Mar 2017 | - | -$1.41 M(-2.0%) | -$6.61 M(-3.7%) |
| Dec 2016 | -$6.86 M(-1.6%) | -$1.44 M(-37.2%) | -$6.86 M(+10.0%) |
| Sep 2016 | - | -$2.29 M(+54.2%) | -$6.24 M(+61.4%) |
| Jun 2016 | - | -$1.48 M(-10.5%) | -$3.87 M(-23.9%) |
| Mar 2016 | - | -$1.66 M(+103.7%) | -$5.08 M(-27.1%) |
| Dec 2015 | -$6.97 M(+122.9%) | -$813.70 K(-1029.9%) | -$6.97 M(-9.4%) |
| Sep 2015 | - | $87.50 K(-103.2%) | -$7.70 M(-30.4%) |
| Jun 2015 | - | -$2.70 M(-24.0%) | -$11.06 M(+15.7%) |
| Mar 2015 | - | -$3.55 M(+131.0%) | -$9.55 M(+205.4%) |
| Dec 2014 | -$3.13 M(-49.2%) | -$1.54 M(-53.0%) | -$3.13 M(+1.2%) |
| Sep 2014 | - | -$3.27 M(+173.4%) | -$3.09 M(+11.5%) |
| Jun 2014 | - | -$1.20 M(-141.6%) | -$2.77 M(+3.4%) |
| Mar 2014 | - | $2.87 M(-291.7%) | -$2.68 M(-56.5%) |
| Dec 2013 | -$6.16 M(+115.0%) | -$1.50 M(-49.2%) | -$6.16 M(+75.6%) |
| Sep 2013 | - | -$2.95 M(+167.1%) | -$3.51 M(+11.9%) |
| Jun 2013 | - | -$1.11 M(+83.2%) | -$3.13 M(+29.6%) |
| Mar 2013 | - | -$603.50 K(-152.4%) | -$2.42 M(-15.6%) |
| Dec 2012 | -$2.87 M(-47.5%) | $1.15 M(-144.7%) | -$2.87 M(-45.1%) |
| Sep 2012 | - | -$2.58 M(+561.2%) | -$5.22 M(+46.3%) |
| Jun 2012 | - | -$389.90 K(-62.9%) | -$3.57 M(-23.2%) |
| Mar 2012 | - | -$1.05 M(-12.8%) | -$4.65 M(+29.2%) |
| Dec 2011 | -$5.46 M(-28.2%) | -$1.20 M(+30.2%) | -$3.60 M(+50.3%) |
| Sep 2011 | - | -$925.00 K(-37.1%) | -$2.40 M(+62.9%) |
| Jun 2011 | - | -$1.47 M | -$1.47 M |
| Dec 2010 | -$7.60 M | - | - |
FAQ
- What is ClearPoint Neuro annual EBITDA?
- What is the all time high annual EBITDA for ClearPoint Neuro?
- What is ClearPoint Neuro annual EBITDA year-on-year change?
- What is ClearPoint Neuro quarterly EBITDA?
- What is the all time high quarterly EBITDA for ClearPoint Neuro?
- What is ClearPoint Neuro quarterly EBITDA year-on-year change?
- What is ClearPoint Neuro TTM EBITDA?
- What is the all time high TTM EBITDA for ClearPoint Neuro?
- What is ClearPoint Neuro TTM EBITDA year-on-year change?
What is ClearPoint Neuro annual EBITDA?
The current annual EBITDA of CLPT is -$20.99 M
What is the all time high annual EBITDA for ClearPoint Neuro?
ClearPoint Neuro all-time high annual EBITDA is -$2.87 M
What is ClearPoint Neuro annual EBITDA year-on-year change?
Over the past year, CLPT annual EBITDA has changed by -$5.41 M (-34.74%)
What is ClearPoint Neuro quarterly EBITDA?
The current quarterly EBITDA of CLPT is -$4.68 M
What is the all time high quarterly EBITDA for ClearPoint Neuro?
ClearPoint Neuro all-time high quarterly EBITDA is $2.87 M
What is ClearPoint Neuro quarterly EBITDA year-on-year change?
Over the past year, CLPT quarterly EBITDA has changed by -$203.00 K (-4.54%)
What is ClearPoint Neuro TTM EBITDA?
The current TTM EBITDA of CLPT is -$16.99 M
What is the all time high TTM EBITDA for ClearPoint Neuro?
ClearPoint Neuro all-time high TTM EBITDA is -$1.47 M
What is ClearPoint Neuro TTM EBITDA year-on-year change?
Over the past year, CLPT TTM EBITDA has changed by +$4.05 M (+19.26%)